Patent Application for Cryogenic Blunt Dissection Methods and Devices
Summary
The USPTO has published a new patent application (US20260083491A1) filed by Pacira CryoTech, Inc. The application details methods and devices for cryogenic blunt dissection of tissue, specifically targeting the temporoparietal fascia layer for therapeutic effects on nerves. The filing date was December 3, 2025.
What changed
This document is a publication of a new patent application, US20260083491A1, filed by Pacira CryoTech, Inc. The application describes a novel method and device for cryogenic blunt dissection of tissue, particularly the temporoparietal fascia-deep temporoparietal fascia layer (TPF-sDTF). The technique involves creating an incision laterally displaced from a target nerve, inserting a cryogenic probe, and using it to dissect tissue and apply cryogenic treatment directly adjacent to a portion of the target nerve to achieve a therapeutic effect.
As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future developments in medical devices and therapeutic techniques within the healthcare sector. Companies involved in prosthetics, medical devices, or surgical procedures should monitor the progress of this patent application and related technologies for potential competitive or licensing implications.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Cryogenic Blunt Dissection Methods and Devices
Application US20260083491A1 Kind: A1 Mar 26, 2026
Assignee
Pacira CryoTech, Inc.
Inventors
John Allison
Abstract
A point of incision is created within tissue, the tissue having a temporoparietal fascia-deep temporoparietal fascia layer (TPF-sDTF) beneath skin and a temporal branch of a target nerve extending along a portion of the TPF-sDTF, the point of incision being laterally displaced from the target nerve. A cryogenic probe having a distal tip extending from an elongated body is inserted into the point of incision. The TPF-sDTF is bluntly dissected using the cryogenic probe such that a treating portion of the cryogenic probe is directly adjacent to a first treatment portion of the target nerve. The cryogenic probe is activated to create a first treatment zone at the first treatment portion of the target nerve to cause a therapeutic effect.
CPC Classifications
A61B 18/02 A61F 7/00 A61B 2018/00023 A61B 2018/00321 A61B 2018/00434 A61B 2018/00452 A61B 2018/0262 A61B 2018/0293
Filing Date
2025-12-03
Application No.
19407715
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.